Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1970 2
1975 1
1976 1
1977 6
1978 3
1979 1
1980 3
1981 3
1982 4
1983 1
1984 2
1985 2
1986 2
1987 2
1988 2
1989 4
1990 2
1991 2
1992 2
1993 4
1994 5
1995 4
1996 1
1997 1
1998 4
2000 4
2001 4
2002 6
2003 9
2004 9
2005 6
2006 12
2007 10
2008 3
2009 6
2010 17
2011 18
2012 13
2013 8
2014 11
2015 19
2016 8
2017 15
2018 18
2019 14
2020 14
2021 22
2022 23
2023 20
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
Werth VP, Joly P, Mimouni D, Maverakis E, Caux F, Lehane P, Gearhart L, Kapre A, Pordeli P, Chen DM; PEMPHIX Study Group. Werth VP, et al. Among authors: chen dm. N Engl J Med. 2021 Jun 17;384(24):2295-2305. doi: 10.1056/NEJMoa2028564. Epub 2021 May 19. N Engl J Med. 2021. PMID: 34097368 Clinical Trial.
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.
Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases. Chen DM, et al. Br J Dermatol. 2020 May;182(5):1111-1119. doi: 10.1111/bjd.18482. Epub 2019 Nov 28. Br J Dermatol. 2020. PMID: 31487383 Free PMC article. Clinical Trial.
LncRNA SNHG5: A new budding star in human cancers.
Li YH, Hu YQ, Wang SC, Li Y, Chen DM. Li YH, et al. Among authors: chen dm. Gene. 2020 Jul 30;749:144724. doi: 10.1016/j.gene.2020.144724. Epub 2020 May 1. Gene. 2020. PMID: 32360843 Review.
A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
Jacobson ME, Rick JW, Gerbens LAA, Baghoomian W, Gould LJ, Marzano AV, Chen DM, Oakes DL, Dissemond J, Yamamoto T, Shinkai K, Nolan B, Lobato D, Thomas KS, Ortega-Loayza AG; UPGRADE. Jacobson ME, et al. Among authors: chen dm. Br J Dermatol. 2024 Feb 16;190(3):392-401. doi: 10.1093/bjd/ljad420. Br J Dermatol. 2024. PMID: 37952167 Review.
Real-world evidence regarding the growth of very premature infants with small for gestational age after birth: a multicenter survey in China.
Huang XR, Shen W, Wu F, Mao J, Liu L, Chang YM, Zhang R, Ye XZ, Qiu YP, Ma L, Cheng R, Wu H, Chen DM, Chen L, Xu P, Mei H, Wang SN, Xu FL, Ju R, Zheng Z, Lin XZ, Tong XM; Chinese Multicenter EUGR Collaborative Group. Huang XR, et al. Among authors: chen dm. BMC Pediatr. 2023 Aug 31;23(1):437. doi: 10.1186/s12887-023-04245-1. BMC Pediatr. 2023. PMID: 37653371 Free PMC article.
Fibrinogen, fibrin degradation products and risk of sarcopenia.
Chen JL, Chen DM, Luo C, Sun Y, Zhao YX, Huang CQ, Zhao KX, Xiao Q. Chen JL, et al. Among authors: chen dm. Clin Nutr. 2021 Aug;40(8):4830-4837. doi: 10.1016/j.clnu.2021.06.031. Epub 2021 Jul 6. Clin Nutr. 2021. PMID: 34358823
338 results